D
Ditto Bio develops evolutionary therapies by leveraging insights from parasite biology to treat autoimmune diseases. The company utilizes an AI platform to screen parasite proteins that modulate the immune system for therapeutic potential. This approach aims to discover novel drug candidates for conditions like rheumatoid arthritis and multiple sclerosis.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Ditto Bio develops evolutionary therapies by leveraging insights from parasite biology to treat autoimmune diseases. The company utilizes an AI platform to screen parasite proteins that modulate the immune system for therapeutic potential. This approach aims to discover novel drug candidates for conditions like rheumatoid arthritis and multiple sclerosis.